Pharm-话题@MedSci

#Pharm#

730篇内容 | 2580人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1787738, encodeId=a6ff1e8773840, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Noxopharm的TBK1抑制剂idronoxil I期临床试验显示新冠肺炎患者有抗炎应答, objectType=article, longId=216356, objectId=c32b21635692, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c32b21635692, replyNumber=0, likeNumber=88, createdTime=2021-10-17, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c32b21635692, moduleTitle=Noxopharm的TBK1抑制剂idronoxil I期临床试验显示新冠肺炎患者有抗炎应答, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c32b21635692)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787740, encodeId=dbf21e8774075, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Aliment Pharmacol Ther：炎症性肠病诊断前后的合并症, objectType=article, longId=216483, objectId=23742164837d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23742164837d, replyNumber=0, likeNumber=59, createdTime=2021-10-22, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23742164837d, moduleTitle=Aliment Pharmacol Ther：炎症性肠病诊断前后的合并症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23742164837d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787748, encodeId=fffa1e8774807, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Front Pharmacol：中草药皂苷对心肌缺血再灌注损伤的保护作用, objectType=article, longId=217944, objectId=ee1221e9444c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee1221e9444c, replyNumber=0, likeNumber=65, createdTime=2022-01-08, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee1221e9444c, moduleTitle=Front Pharmacol：中草药皂苷对心肌缺血再灌注损伤的保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee1221e9444c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787737, encodeId=0e101e8773736, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=FRONT PHARMACOL：非诺贝特可以将新冠感染减少超70%, objectType=article, longId=216024, objectId=0479216024a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0479216024a8, replyNumber=0, likeNumber=109, createdTime=2021-11-09, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0479216024a8, moduleTitle=FRONT PHARMACOL：非诺贝特可以将新冠感染减少超70%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0479216024a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787709, encodeId=923f1e877095d, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Expert Rev Clin Pharmacol：与非维生素K拮抗剂口服抗凝剂的药物相互作用在老年患者中风预防中的新近进展, objectType=article, longId=209245, objectId=cbb02092451b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbb02092451b, replyNumber=0, likeNumber=49, createdTime=2021-05-10, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbb02092451b, moduleTitle=Expert Rev Clin Pharmacol：与非维生素K拮抗剂口服抗凝剂的药物相互作用在老年患者中风预防中的新近进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbb02092451b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787722, encodeId=6fb81e8772287, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Aliment Pharmacol Ther：二甲双胍对肝硬化门静脉高压症患者门静脉压的急性影响, objectType=article, longId=213389, objectId=e55e21338932, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e55e21338932, replyNumber=0, likeNumber=53, createdTime=2022-06-10, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e55e21338932, moduleTitle=Aliment Pharmacol Ther：二甲双胍对肝硬化门静脉高压症患者门静脉压的急性影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e55e21338932)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787721, encodeId=175a1e87721a3, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Prog Neuropsychopharmacol Biol Psychiatry：伴有胃肠道症状的重度抑郁症患者的脑结构发生改变, objectType=article, longId=213276, objectId=5eb32132e607, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5eb32132e607, replyNumber=0, likeNumber=70, createdTime=2021-07-15, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5eb32132e607, moduleTitle=Prog Neuropsychopharmacol Biol Psychiatry：伴有胃肠道症状的重度抑郁症患者的脑结构发生改变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5eb32132e607)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787714, encodeId=a1a61e87714f3, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=临床数据显示，Noxopharm的Veyonda®或可预防细胞因子风暴, objectType=article, longId=210640, objectId=47c62106408e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47c62106408e, replyNumber=0, likeNumber=64, createdTime=2022-02-14, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47c62106408e, moduleTitle=临床数据显示，Noxopharm的Veyonda®或可预防细胞因子风暴, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47c62106408e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787726, encodeId=ceb11e87726de, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Neuropsychopharmacology：白质纤维缺陷可能是精神分裂症患者异常应激反应的罪魁祸首, objectType=article, longId=214512, objectId=64ff21451213, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64ff21451213, replyNumber=0, likeNumber=93, createdTime=2022-05-26, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64ff21451213, moduleTitle=Neuropsychopharmacology：白质纤维缺陷可能是精神分裂症患者异常应激反应的罪魁祸首, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64ff21451213)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787734, encodeId=d74c1e87734b0, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=ENYO Pharma发布进行中的两项Vonafexor (EYP001)治疗慢性乙型肝炎患者2a期研究16周顶线中期结果, objectType=article, longId=215346, objectId=4dff215346ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4dff215346ac, replyNumber=0, likeNumber=69, createdTime=2022-01-21, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4dff215346ac, moduleTitle=ENYO Pharma发布进行中的两项Vonafexor (EYP001)治疗慢性乙型肝炎患者2a期研究16周顶线中期结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4dff215346ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787695, encodeId=b85c1e876954f, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Pharmacol Res：瑞德西韦治疗住院SARS-CoV-2肺炎患者的疗效, objectType=article, longId=204108, objectId=e43220410849, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e43220410849, replyNumber=0, likeNumber=60, createdTime=2021-08-26, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e43220410849, moduleTitle=Pharmacol Res：瑞德西韦治疗住院SARS-CoV-2肺炎患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e43220410849)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787698, encodeId=ef4a1e8769894, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=FDA批准Karyopharm的Xpovio（selinexor）用于治疗多发性骨髓瘤, objectType=article, longId=204714, objectId=6286204e1417, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6286204e1417, replyNumber=0, likeNumber=84, createdTime=2021-12-04, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6286204e1417, moduleTitle=FDA批准Karyopharm的Xpovio（selinexor）用于治疗多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6286204e1417)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787706, encodeId=4a841e8770658, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Aliment Pharmacol Ther：补充BB-12可有效控制婴儿肠绞痛, objectType=article, longId=207458, objectId=9a3b20e45873, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a3b20e45873, replyNumber=0, likeNumber=51, createdTime=2021-07-19, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a3b20e45873, moduleTitle=Aliment Pharmacol Ther：补充BB-12可有效控制婴儿肠绞痛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a3b20e45873)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787691, encodeId=0e8f1e8769129, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Br J Clin Pharmacol：HPV疫苗在男性中安全耐受性良好，HPV疫苗之父：男性也应接种, objectType=article, longId=202983, objectId=5e91202983bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e91202983bf, replyNumber=0, likeNumber=83, createdTime=2021-05-25, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e91202983bf, moduleTitle=Br J Clin Pharmacol：HPV疫苗在男性中安全耐受性良好，HPV疫苗之父：男性也应接种, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e91202983bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787685, encodeId=865a1e8768526, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Aliment Pharm Ther：适度喝咖啡，就可以降低近一半的肝病死亡率？, objectType=article, longId=200123, objectId=40e920012304, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40e920012304, replyNumber=0, likeNumber=60, createdTime=2020-10-15, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40e920012304, moduleTitle=Aliment Pharm Ther：适度喝咖啡，就可以降低近一半的肝病死亡率？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40e920012304)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787713, encodeId=87be1e87713b8, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Noxopharm为Veyonda®申请败血症休克治疗专利, objectType=article, longId=210373, objectId=b1fe2103e3f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1fe2103e3f3, replyNumber=0, likeNumber=62, createdTime=2021-06-16, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1fe2103e3f3, moduleTitle=Noxopharm为Veyonda®申请败血症休克治疗专利, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1fe2103e3f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787724, encodeId=201d1e8772449, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Aliment Pharmacol Ther：中心性肥胖的慢性乙肝患者发展成肝癌的风险增加了两倍！, objectType=article, longId=213448, objectId=4a2021344866, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a2021344866, replyNumber=0, likeNumber=87, createdTime=2021-10-18, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a2021344866, moduleTitle=Aliment Pharmacol Ther：中心性肥胖的慢性乙肝患者发展成肝癌的风险增加了两倍！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a2021344866)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787720, encodeId=34851e8772054, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Neuropsychopharmacology：结构连接体的测量可能有助于预测青年双相情感障碍的药物治疗结果, objectType=article, longId=213272, objectId=65822132e265, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65822132e265, replyNumber=0, likeNumber=61, createdTime=2021-10-23, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65822132e265, moduleTitle=Neuropsychopharmacology：结构连接体的测量可能有助于预测青年双相情感障碍的药物治疗结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65822132e265)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787690, encodeId=eb5a1e87690a1, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Pharmaceutics：壳聚糖水凝胶掺杂PEG-PLA纳米颗粒来局部递送miRNA-146a和治疗变应性鼻炎, objectType=article, longId=202457, objectId=68f020245ef3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68f020245ef3, replyNumber=0, likeNumber=63, createdTime=2021-02-07, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68f020245ef3, moduleTitle=Pharmaceutics：壳聚糖水凝胶掺杂PEG-PLA纳米颗粒来局部递送miRNA-146a和治疗变应性鼻炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68f020245ef3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787702, encodeId=84b71e877025a, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=ARTMS和Telix Pharmaceuticals宣布利用从固态靶材通过回旋加速器产出的68Ga，成功生产出PSMA-11试剂盒, objectType=article, longId=205740, objectId=214b205e4021, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=214b205e4021, replyNumber=0, likeNumber=64, createdTime=2021-04-14, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=214b205e4021, moduleTitle=ARTMS和Telix Pharmaceuticals宣布利用从固态靶材通过回旋加速器产出的68Ga，成功生产出PSMA-11试剂盒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=214b205e4021)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Pharm

2020-05-29

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Noxopharm的TBK1抑制剂idronoxil I期临床试验显示新冠肺炎患者有抗炎应答

2021-10-17

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Aliment Pharmacol Ther：炎症性肠病诊断前后的合并症

2021-10-22

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Front Pharmacol：中草药皂苷对心肌缺血再灌注损伤的保护作用

2022-01-08

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

FRONT PHARMACOL：非诺贝特可以将新冠感染减少超70%

2021-11-09

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Expert Rev Clin Pharmacol：与非维生素K拮抗剂口服抗凝剂的药物相互作用在老年患者中风预防中的新近进展

2021-05-10

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Aliment Pharmacol Ther：二甲双胍对肝硬化门静脉高压症患者门静脉压的急性影响

2022-06-10

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Prog Neuropsychopharmacol Biol Psychiatry：伴有胃肠道症状的重度抑郁症患者的脑结构发生改变

2021-07-15

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

临床数据显示，Noxopharm的Veyonda®或可预防细胞因子风暴

2022-02-14

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Neuropsychopharmacology：白质纤维缺陷可能是精神分裂症患者异常应激反应的罪魁祸首

2022-05-26

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

ENYO Pharma发布进行中的两项Vonafexor (EYP001)治疗慢性乙型肝炎患者2a期研究16周顶线中期结果

2022-01-21

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Pharmacol Res：瑞德西韦治疗住院SARS-CoV-2肺炎患者的疗效

2021-08-26

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

FDA批准Karyopharm的Xpovio（selinexor）用于治疗多发性骨髓瘤

2021-12-04

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Aliment Pharmacol Ther：补充BB-12可有效控制婴儿肠绞痛

2021-07-19

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Br J Clin Pharmacol：HPV疫苗在男性中安全耐受性良好，HPV疫苗之父：男性也应接种

2021-05-25

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Aliment Pharm Ther：适度喝咖啡，就可以降低近一半的肝病死亡率？

2020-10-15

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Noxopharm为Veyonda®申请败血症休克治疗专利

2021-06-16

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Aliment Pharmacol Ther：中心性肥胖的慢性乙肝患者发展成肝癌的风险增加了两倍！

2021-10-18

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Neuropsychopharmacology：结构连接体的测量可能有助于预测青年双相情感障碍的药物治疗结果

2021-10-23

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Pharmaceutics：壳聚糖水凝胶掺杂PEG-PLA纳米颗粒来局部递送miRNA-146a和治疗变应性鼻炎

2021-02-07

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

ARTMS和Telix Pharmaceuticals宣布利用从固态靶材通过回旋加速器产出的68Ga，成功生产出PSMA-11试剂盒

2021-04-14

科室
- - 订阅+
  - 更多科室
工具
服务